ΨΥΧΟΛΟΓΙΑ - Έρευνα και Εφαρμογές ΤΕΥΧΟΣ 4ο | Page 68

ΙSSN: 2623- 3673
Φεβρουάριος, 2019
Ψυχολογία :έρευνα & εφαρμογές
39 . Larsen J, Vedtofte L, Jakobsen M, Jespersen H, Jakobsen M, Svensson C,
Koyuncu K, Schjerning O, Oturai P, Kjaer A, Nielsen J, Holst J, Ekstrøm C,
Correll C, Vilsbøll T, Fink-Jensen A.JAMA Psychiatry. 2017 Jul 1;74(7):719-
728. Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity
in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum
Disorder: A Randomized Clinical Trial.
40. Horska K, Ruda-Kucerova J, Drazanova E, Karpisek M, Demlova R,
Kasparek T, Kotolova H
Neuropharmacology. 2017 Sep 1;123:148-158.
Aripiprazole-induced
adverse
metabolic
alterations
in
polyI:C
neurodevelopmental model of schizophrenia in rats.
41. Huang Y, Ma H, Wang Y, Peng M, Zhu G. Neuropsychiatr Dis Treat. 2017
May 24;13:1395-1397. Topiramate add-on treatment associated with
normalization of prolactin levels in a patient with schizophrenia.
42.Garnock-Jones K. CNS Drugs. 2017 Jun;31(6):513-525. Cariprazine: A
Review in Schizophrenia.
43. Zhang C, Fang X, Yao P, Mao Y, Cai J, Zhang Y, Chen M, Fan W, Tang W,
Song L. Psychoneuroendocrinology. 2017 Jul;81:138-143. Metabolic adverse
effects of olanzapine on cognitive dysfunction: A possible relationship between
BDNF and TNF-alpha.
44. Goldman R, Loebel A, Cucchiaro J, Deng L, Findling R. J Child Adolesc
Psychopharmacol. 2017 Aug;27(6):516-525. Efficacy and Safety of Lurasidone
in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled
Study.
45. Stefanidis A, Watt M, Cowley M, Oldfield B. Neuropharmacology. 2017 Sep
1;123:55-66. Prevention of the adverse effects of olanzapine on lipid metabolism
with the antiepileptic zonisamide.
46. Lazzari P, Serra V, Marcello S, Pira M, Mastinu A. Eur
Neuropsychopharmacol. 2017 Jul;27(7):667-678. Metabolic side effects induced
by olanzapine treatment are neutralized by CB1 receptor antagonist compounds
co-administration in female rats.
47. Srisawasdi P, Vanwong N, Hongkaew Y, Puangpetch A, Vanavanan S,
Intachak B, Ngamsamut N, Limsila P, Sukasem C, Kroll M. Clin Biochem. 2017
Aug;50(12):678-685. Impact of risperidone on leptin and insulin in children and
adolescents with autistic spectrum disorders.
48. Kritharides L, Chow V, Lambert T. Med J Aust. 2017 Feb 6;206(2):91-95.
Cardiovascular disease in patients with schizophrenia.
49. Ndukwe H, Nishtala P. Arch Gerontol Geriatr. 2017 May - Jun;70:136-140.
Glucose monitoring in new users of second-generation antipsychotics in older
people.
50. Rimessi A, Pavan C, Ioannidi E, Nigro F, Morganti C, Brugnoli A, Longo F,
Gardin C, Ferroni L, Morari M, Vindigni V, Zavan B, Pinton P.
Neuropsychopharmacology. 2017 Jun;42(7):1491-1501. Protein Kinase C β: a
New Target Therapy to Prevent the Long-Term Atypical Antipsychotic-Induced
Weight Gain.